Vela Ramirez, J E <br/><br/>
Carbohydrate-functionalized nanovaccines preserve HIV-1 antigen stability and activate antigen presenting cells.  [electronic resource] 

 -  Journal of biomaterials science. Polymer edition  2014 
 - 1387-406 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>1568-5624 
<br/><br/><label>Standard No.: </label>10.1080/09205063.2014.940243  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>AIDS Vaccines--chemistry<br/>Adjuvants, Immunologic<br/>Animals<br/>CD40 Antigens--metabolism<br/>Carbohydrates--chemistry<br/>Cells, Cultured<br/>Dendritic Cells--immunology<br/>HIV Envelope Protein gp41--chemistry<br/>HIV-1--immunology<br/>Interleukin-6--metabolism<br/>Lectins, C-Type--metabolism<br/>Mannose Receptor<br/>Mannose-Binding Lectins--metabolism<br/>Mice, Inbred C57BL<br/>Nanoparticles--chemistry<br/>Polyanhydrides--chemistry<br/>Receptors, Cell Surface--metabolism<br/>Tumor Necrosis Factor-alpha--metabolism<br/>Vaccines, Synthetic